53 tablets, including Paracetamol, fail quality tests: Central Drug report

In a recent report, the Central Drug Quality Control Organization (CDASCO) revealed that 53 medicines, including commonly used drugs like paracetamol, diabetes medications, blood pressure tablets, and vitamins, have failed quality tests. Some of these medicines have even been flagged as toxic, raising concerns over their safety. 

The CDASCO conducts monthly sample testing across various parts of the country to ensure the quality of medicines. Their latest report includes findings that several medications, including vitamin C, Shellcall, a vitamin D supplement, vitamin B complex, and antacids such as Pan D, have failed the quality test. Drugs like Paracetamol IP 500 mg, Glimepiride used for diabetes, and Telmisartan prescribed for high blood pressure were also listed.

Biotin Boost: Unveiling the advantages and uses of biotin for enhanced hair health

Notably, the paracetamol tablet that failed the test is produced by Karnataka Antibiotics and Pharmaceuticals Ltd. At the same time, other drugs are manufactured by companies such as Hetero Drugs, Alchem Labs, Hindustan Antibiotics, Mail Life Sciences, and Pure and Cure Healthcare.

Bengaluru: CCB police seize MDMA drugs worth Rs 1.5 crore from Nigerian man and girlfriend

The report also highlighted that Alchem Labs’ Clavum 625 and Pan D drugs were found to be toxic. However, Alchem Labs denied producing the specific batches that were flagged in the report.

This monthly report serves as a warning to both consumers and healthcare professionals about the potential risks associated with certain medications. CDASCO’s stringent testing ensures that substandard drugs are identified and actions are taken to safeguard public health.